x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Decera Clinical Education Infectious Disease Podcast

Decera Clinical Education

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.

education courses

All Episodes

00:45:21

Tackling Racial Disparities in HBV Care

Decera Clinical Education Infectious Disease Podcast ·

2021/09/03

In this episode, Mindie H. Nguyen, MD, MAS, AGAF, FAASLD, and Lewis R. Roberts, MB ChB, PhD, examine the HBV burden and care disparities in specific populations, including Asian Americans and foreign-born immigrants, and strategies to address barriers to care.Presenters:Mindie H. Nguyen, MD, MAS, AGAF, FAASLDProfessor of MedicineDepartment of Gastroenterology and HepatologyStanford University Medical CenterPalo Alto, CaliforniaLewis R. Roberts, MB ChB, PhDProfessor of Medicine and ConsultantDivision

en

00:11:19

Contemporary Management of HIV 2021: Heavily...

Decera Clinical Education Infectious Disease Podcast ·

2021/09/02

In this series of 3 episodes, Geeta Gupta, MD, discusses strategies for optimizing ART in heavily treatment–experienced patients with HIV, including management of virologic failure and switching ART in virologically suppressed patients with underlying resistance. The 3 episodes will include analyses from:BENCHMRK, which demonstrated that the number of active drugs predicts outcomes in treatment-experienced patientsTMB-301, a study that added the monoclonal antibody ibalizumab in pretreated patients

en

00:13:44

Contemporary Management of HIV 2021: Heavily...

Decera Clinical Education Infectious Disease Podcast ·

2021/09/01

In this series of 3 episodes, Geeta Gupta, MD, discusses strategies for optimizing ART in heavily treatment–experienced patients with HIV, including management of virologic failure and switching ART in virologically suppressed patients with underlying resistance. The 3 episodes will include analyses from:BENCHMRK, which demonstrated that the number of active drugs predicts outcomes in treatment-experienced patientsTMB-301, a study that added the monoclonal antibody ibalizumab in pretreated patients

en

00:14:08

Key Decisions in HIV Care: Weight Gain in ART

Decera Clinical Education Infectious Disease Podcast ·

2021/08/30

In this episode, Joseph J. Eron, Jr., MD, explores whether weight gain should or should not be a factor in determining initial therapy.Listen as he gives his perspectives on:Weight gain following ART initiation by ARV class and ARV drugResults of the ADVANCE and GEMINI-1 and -2 studies, with exploration of weight, risk of CVD and diabetesBMI changes in PWHDHHS and IAS-USA guidelines for initial therapyPresenter:Joseph J. Eron, MDProfessor of Medicine and EpidemiologyUniversity of North Carolina

en

00:47:49

Contemporary Management of HIV 2021: Modifying ART in...

Decera Clinical Education Infectious Disease Podcast ·

2021/08/25

In this episode, David Malebranche, MD, MPH, discusses modifying ART in virologically suppressed patients, including switching ART in a patient with daily pill fatigue, switching ART to avoid comorbidities and simplifying ART in the context of known multidrug resistance. The overview will include analyses from:The ATLAS and FLAIR studies in which long-acting intramuscular CAB + RPV was initiated after initial virologic suppression with oral therapyD:A:D study data that found cumulative use of

en

00:30:19

Contemporary Management of HIV 2021: Emerging...

Decera Clinical Education Infectious Disease Podcast ·

2021/08/25

In this episode, Paul E. Sax, MD, discusses emerging drug therapies and treatment options for patients with HIV, including rapid initiation of ART, long-acting ART, and 2-drug ART regimens. The overview will include analyses from:The RAPID ART program in San Francisco, where same-day initiation of ART led to faster HIV-1 RNA suppression that was maintained at greater than 92% during a 3-year periodThe DIAMOND study analyzing virologic efficacy and safety at 48 weeks after initiating DRV/COBI/FTC/TAF

en

00:52:50

Conference Conversations: Pharmacist Perspectives...

Decera Clinical Education Infectious Disease Podcast ·

2021/08/23

In this episode, Jennifer Cocohoba, PharmD, and Jason Schafer, PharmD, MPH, discuss key studies from IAS 2021 that will influence the role of the pharmacist in the treatment and prevention of HIV. Their discussion includes analyses of:The 144-week analysis of the TANGO study, showing high rates of virologic suppression of patients switched from a TAF-containing regimen to DTG plus 3TCThe 144-week analysis of the TANGO study, showing high rates of virologic suppression of patients switched from a

en

00:45:41

Key Studies Influencing My Practice Following IAS...

Decera Clinical Education Infectious Disease Podcast ·

2021/08/19

In this episode, Babafemi Taiwo, MBBS, discusses new HIV data from IAS 2021, including:WHO Global Clinical Platform: COVID-19 outcomes in PWH2-drug regimen of DTG/3TC: efficacy, metabolic outcomes (TANGO)Investigational antiretroviral useCAB LA + RPV LA in treatment-naive PWH (FLAIR)Investigational antiretroviral agentsLEN (CAPELLA, CALIBRATE)ISL (P011, P016)Alternative BPaL dosing in treatment of drug-resistant TB (ZeNix)Babafemi Taiwo, MBBSGene Stollerman Professor of MedicineChief, Division of

en

00:28:02

Optimizing Use of Oral HIV PrEP

Decera Clinical Education Infectious Disease Podcast ·

2021/08/12

During this episode, Darrell H. S. Tan, MD, FRCPC, PhD, discusses approved and guideline-recommended oral HIV PrEP regimens and provides key insights on determining PrEP candidacy as well as important considerations for specific populations/clinical scenarios, including adolescents, pregnancy/breastfeeding, and transgender individuals.Presenter:Darrell H. S. Tan, MD, FRCPC, PhDAssociate Professor Division of Infectious DiseasesUniversity of TorontoClinician-ScientistDivision of Infectious

en

00:15:11

The HBV Gray Zone: Patient and Physician Sharing...

Decera Clinical Education Infectious Disease Podcast ·

2021/07/28

In episode 5 of an ongoing series of sharing sessions between a physician and patient, Anna Christina L. dela Cruz, MD, and Rhonda, who is living with chronic hepatitis B, discuss what to do when the decision to start treatment is not clear because of borderline ALT test results and HBV DNA levels. Their conversation highlights a need for patient education and shared decision-making.Presenter:Anna Christina L. dela Cruz, MDAssociate ProfessorDivision of Digestive Diseases and NutritionDepartment of

en

00:24:06

Hepatitis B Reactivation: Patient and Physician...

Decera Clinical Education Infectious Disease Podcast ·

2021/07/26

In episode 4 of an ongoing series of sharing sessions between a physician and patient, Geoffrey M. Dusheiko, MD, FCP(SA), FRCP, discusses hepatitis B diagnosis and treatment with his patient, Mark. The conversation focuses on Mark’s missed HBV diagnosis and likely reactivation following treatment for rheumatoid arthritis and raises awareness for needed improvements to communication between multidisciplinary healthcare teams. Presenter:Geoffrey M. Dusheiko MD, FCP(SA), FRCPEmeritus Professor of

en

00:45:05

Tackling Racial Disparities in HCV Care

Decera Clinical Education Infectious Disease Podcast ·

2021/07/22

In this episode, Oluwaseun Falade-Nwulia, MBBS, MPH, and Joseph K. Lim, MD, examine the HCV burden and care disparities in specific populations, including Black, Hispanic, Asian, American Indian, and Alaska Native persons, and strategies to address barriers to care.Oluwaseun Falade-Nwulia, MBBS, MPHAssociate ProfessorDivision of Infectious DiseasesJohns Hopkins University School of MedicineAttendingDivision of Infectious DiseasesJohns Hopkins HospitalBaltimore, MarylandJoseph K. Lim, MDProfessor of

en

00:52:27

Virtual EASL 2021: Rapid Audio Recap

Decera Clinical Education Infectious Disease Podcast ·

2021/07/19

In this episode, Stefan Zeuzem, MD, discusses exciting new data on viral hepatitis reported at the virtual EASL 2021, including new findings on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.Stefan Zeuzem, MDProfessor of MedicineChief, Department of Medicine IJW Goethe University Hospital Frankfurt, GermanyContent based on a CME program supported by educational grants provided by AbbVie, Antios Therapeutics, and

en

00:31:08

An HIV Vaccine: An Unfulfilled Promise—Episode 4,...

Decera Clinical Education Infectious Disease Podcast ·

2021/07/16

Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode,Drs Elizabeth Bukusi, Peter Godfrey-Faussett, and Nina

en

00:51:35

Respiratory Syncytial Virus in Older Adults:...

Decera Clinical Education Infectious Disease Podcast ·

2021/07/15

In this podcast, Spencer H. Durham, PharmD, BCPS, BCIDP; Stefan Gravenstein, MD, MPH; and Barbara Resnick, PhD, CRNP, discuss risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccines for older adults. Following their dialogue, the faculty field questions from healthcare professionals.Presenters:Spencer H. Durham, PharmD, BCPS, BCIDP Associate Clinical Professor of Pharmacy Practice Director,

en

00:33:50

An HIV Vaccine: An Unfulfilled Promise—Episode 3,...

Decera Clinical Education Infectious Disease Podcast ·

2021/07/13

Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Swati Gupta and Mr. Marc Dixneuf discuss how to broaden

en

00:43:54

HIV-ASSIST: A Free, Online Tool for Individualized,...

Decera Clinical Education Infectious Disease Podcast ·

2021/07/08

In this episode, Jehan Budak, MD, discusses the use of HIV-ASSIST, a free, online, decision-support tool to inform ART selection.Jehan Budak, MDAssistant ProfessorDivision of Allergy & Infectious DiseasesUniversity of WashingtonSeattle, WashingtonContent based on a CME program supported by educational grants from Gilead Sciences, Inc.; Theratechnologies; and ViiV Healthcare.Link to full program:https://bit.ly/33RZ9Zy

en

00:22:09

Key Decisions in HIV Care: Initiating PrEP

Decera Clinical Education Infectious Disease Podcast ·

2021/07/07

In this episode, Latesha Elopre, MD, MSPH, explains how to initiate pre-exposure prophylaxis (PrEP), including in underserved communities, with examples on overcoming barriers and improving access.Listen as she gives her perspectives on:Evidence for PrEP efficacy in the DISCOVER studyRecommendations in MSM, heterosexual men and women, injection drug users, and adolescents and adults weighing more than 77 lbCDC guidanceHow PrEP is underused, including racial/ethnic disparitiesStrategies to overcoming

en

00:15:45

Key Decisions in HIV Care: Switching to Long-Acting ART

Decera Clinical Education Infectious Disease Podcast ·

2021/07/07

In this episode, Daniel J. Kuritzkes, MD, reviews key clinical trial data and gives practical insights such as how to initiate a patient on long-acting therapy, recommended dosing regimens, and factors that may increase the risk of treatment failure. The overview will include analyses of:ATLAS and FLAIR studies of long-acting injectable CAB + RPVATLAS 2M dosing studyFDA approval and DHHS statement on use of long-acting injectable ARTStudies on whether an oral lead-in is neededPresenter:Daniel R

en

00:41:04

Emerging Insights on Adverse Events During ART and...

Decera Clinical Education Infectious Disease Podcast ·

2021/07/06

In this episode, Joseph J. Eron, Jr., MD, and Darcy Wooten, MD, share insights on HIV antiretroviral therapy safety and tolerability including recent data on weight gain and metabolic implications with INSTIs and NRTIs as well as the latest updates and recommendations on dolutegravir and pregnancy.Joseph J. Eron, Jr., MDProfessor of Medicine and EpidemiologyUniversity of North Carolina School of MedicineDirector, AIDS Clinical Trials UnitUniversity of North CarolinaChapel Hill, North CarolinaDarcy

en

498 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College